Posts

Posted on

Lamar Advertising Launching Corporate-Sponsored SPAC: Lamar Partnering Corporation

BATON ROUGE, La., April 06, 2021 (GLOBE NEWSWIRE) — Lamar Advertising Company (Nasdaq: LAMR) announced today that Lamar Partnering Corporation (“LPC”), a newly formed special purpose acquisition company and an indirect wholly-owned subsidiary of Lamar Advertising Company (“Lamar”), has filed a Registration Statement on Form S-1 (the “Registration Statement”) with the Securities and Exchange Commission (“SEC”) in connection with a proposed initial public offering of its units.

LPC plans to search for a partner at the intersection of the out-of-home advertising, technology and communications sectors. ‎It is the intent of LPC that any such partner will not compete with Lamar’s REIT-focused ‎acquisition strategy.‎

The proposed public offering is expected to have a base offering size of $300 million, or up to $345 million if the underwriters’ over-allotment is exercised in full. Under the terms of the proposed public offering, Lamar, through an indirect wholly owned subsidiary (the “Sponsor”), would own approximately 20% of LPC’s issued and outstanding ordinary shares upon the consummation of the offering and the Sponsor expects to commit to acquire $100 million of forward purchase units (each consisting of one share of LPC’s Class B ordinary shares and one-fourth of one warrant to purchase one share of LPC’s Class A ordinary shares) pursuant to a forward purchase agreement that would close substantially concurrent with the consummation of LPC’s initial business combination. Lamar’s ownership interest in LPC will consist primary of Class B ordinary shares following the consummation of LPC’s initial business combination.

LPC will be managed by members of Lamar’s management team, including Ross Reilly, Lamar’s Vice President of Mergers and Acquisitions and Business Analytics, who will serve as LPC’s Chief Executive Officer.

Lamar is a Real Estate Investment Trust that operates more than 357,500 billboard, interstate logo, transit and airport advertising displays across the United States and Canada, including more than 3,600 large-format digital displays.

LPC expects to apply to list the units to be issued in the public offering with the Nasdaq Stock Market to trade under the ticker symbol “LPCXU.” Each such unit will consist of one share of LPC’s Class A ordinary shares and one-fourth of one warrant to purchase one share of LPC’s Class A ordinary shares, which, once separated, are expected to trade under the ticker symbols “LPC” and “LPCXW,” respectively.

Morgan Stanley and Citigroup are acting as joint book-running managers for the proposed offering. When available, copies of the prospectus related to the proposed initial offering by LPC may be obtained for free by visiting Edgar on the SEC’s website at www.sec.gov or from Morgan Stanley & Co. LLC, Attn: Prospectus Department, 180 Varick Street, Second Floor, New York, NY 10014 or Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at (800) 831-9146.

The Registration Statement relating to the securities of the LPC has been filed by the SEC but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the Registration Statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Forward-Looking Statements

This press release includes certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the proposed initial public offering of LPC, including the terms thereof and the use of proceeds therefrom, the forward purchase agreement and the listing of LPC’s securities with The Nasdaq Stock Market. These forward-looking statements involve many risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements, including, without limitation, general market conditions. These forward-looking statements speak only as of the date of this press release, and Lamar and LPC each expressly disclaim any obligation or undertaking to disseminate any updates or revisions to any forward-looking statement contained herein to reflect any change in the expectations of Lamar and LPC with regard thereto or any change in events, conditions or circumstances on which any such statement is based. Please refer to the Registration Statement and the publicly filed documents of Lamar, including Lamar’s most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, as applicable, for risks and uncertainties related to the respective business of LPC and Lamar which may affect the statements made in this press release.

Lamar Contact:

Buster Kantrow
Executive Vice President, Lamar Advertising Company
(225) 926-1000
[email protected]



Posted on

TransMedics Stock Trading Halted Today; FDA Advisory Committee to Review Premarket Approval Application for the OCS Heart System

PR Newswire

ANDOVER, Mass., April 6, 2021 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (NASDAQ: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced today that Nasdaq has halted trading of the company’s common stock.

The U.S. Food and Drug Administration’s (FDA) Circulatory System Devices Panel of the Medical Devices Advisory Committee is meeting today to review TransMedics’ Organ Care System™ (OCS) Heart System. The OCS™ Heart System is a portable organ perfusion and monitoring medical device intended to preserve a donated heart in a near-physiologic, beating and perfused state, while continually monitoring and optimizing heart function for eventual transplantation into the recipient.

The Advisory Committee meeting is scheduled for 9:00 a.m. ET. The briefing materials can be found on the FDA website at https://www.fda.gov/advisory-committees/advisory-committee-calendar/april-6-2021-circulatory-system-devices-panel-medical-devices-advisory-committee-meeting#event-materials.

The Circulatory System Devices Panel of the Medical Devices Advisory Committee reviews and evaluates data concerning the safety and effectiveness of marketed and investigational devices for use in the circulatory and vascular systems and makes appropriate recommendations to the FDA.

About TransMedics Group, Inc.
TransMedics is the world’s leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Forward-Looking Statements
This press release contains forward looking statements relating to certain future events. These risks and uncertainties include those identified under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2020, which is available on the SEC’s website at www.sec.gov. Additional information will be made available by our annual and quarterly reports and other filings that we make from time to time with the SEC. These forward-looking statements speak only as of the date of this press release. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by applicable law.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/transmedics-stock-trading-halted-today-fda-advisory-committee-to-review-premarket-approval-application-for-the-ocs-heart-system-301262582.html

SOURCE TransMedics, Inc.

Posted on

The Joint Corp. Acquires 8 Previously Franchised Clinics and Opens 2 Greenfield Clinics, Increasing the Corporate Portfolio to 74 Clinics

SCOTTSDALE, Ariz., April 06, 2021 (GLOBE NEWSWIRE) — The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, reported corporate clinic activity that increased the number of company-owned or managed clinics to 74 as of April 1, 2021.

In January 2021, The Joint Clinic opened one greenfield in the Los Angeles, CA market and on April 1, 2021 opened another greenfield in Yuma, AZ. Also, on April 1, 2021, the company acquired eight previously franchised clinics, all of which are expected to be immediately accretive to the bottom line. Two clinics are in the Phoenix/Scottsdale market and expand the company’s presence in its strong headquarters’ region. Six of the clinics are in North Carolina and resulted from a multi-unit franchisee selling its portfolio of clinics. The North Carolina transaction, made possible by the recent repurchase of regional developer rights for the territory, broadens the company’s foothold in the Southeast. All of these acquisitions were anticipated and included in the company’s guidance as of March 4, 2021, which stated management expects company-owned or managed clinics to increase between 20 and 30, compared to four in 2020, through a combination of both greenfields and franchised clinic purchases.

“We continue to execute our clinic expansion strategy augmenting clinic clusters and leveraging our marketing, operations, and brand recognition,” stated Peter D. Holt, President and Chief Executive Officer of The Joint Corp. “These opportunistic acquisitions further expand our presence in our strong home market and significantly increase our position in the Southeast. As we move through the year, we expect to accelerate building corporate greenfield clinics strategically located within our clusters and new markets. While new greenfield clinics initially suppress the total company earnings, in the long run they are expected to be accretive. We will continue to prioritize growth through greenfield and franchise clinic openings, as we drive toward our goal of 1,000 clinics opened by the end of 2023.”

Forward-Looking Statements

This press release contains statements about future events and expectations that constitute forward-looking statements. Forward-looking statements are based on our beliefs, assumptions and expectations of industry trends, our future financial and operating performance and our growth plans, taking into account the information currently available to us. These statements are not statements of historical fact. Forward-looking statements involve risks and uncertainties that may cause our actual results to differ materially from the expectations of future results we express or imply in any forward-looking statements, and you should not place undue reliance on such statements. Factors that could contribute to these differences include, but are not limited to, the continuing impact of the COVID-19 outbreak on the economy and our operations (including temporary clinic closures, shortened business hours and reduced patient demand), our failure to develop or acquire company-owned or managed clinics as rapidly as we intend, our failure to profitably operate company-owned or managed clinics, and the other factors described in “Risk Factors” in our Annual Report on Form 10-K as filed with the SEC for the year ended December 31, 2020, as updated or revised for any material changes described in any subsequently-filed Quarterly Reports on Form 10-Q or other SEC filings. Words such as, “anticipates,” “believes,” “continues,” “estimates,” “expects,” “goal,” “objectives,” “intends,” “may,” “opportunity,” “plans,” “potential,” “near-term,” “long-term,” “projections,” “assumptions,” “projects,” “guidance,” “forecasts,” “outlook,” “target,” “trends,” “should,” “could,” “would,” “will,” and similar expressions are intended to identify such forward-looking statements. We qualify any forward-looking statements entirely by these cautionary factors. We assume no obligation to update or revise any forward-looking statements for any reason or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance, unless expressed as such, and should only be viewed as historical data.

About The Joint Corp. (NASDAQ: JYNT)

The Joint Corp. (NASDAQ: JYNT) revolutionized access to chiropractic care when it introduced its retail healthcare business model in 2010. Today, the company is making quality care convenient and affordable, while eliminating the need for insurance, for millions of patients seeking pain relief and ongoing wellness. With nearly 600 locations nationwide and over eight million patient visits annually, The Joint is a key leader in the chiropractic industry. Named on Franchise Times “Top 200+ Franchises” and Entrepreneur’s “Franchise 500®” lists, The Joint Chiropractic is an innovative force, where healthcare meets retail. For more information, visit www.thejoint.com. To learn about franchise opportunities, visit www.thejointfranchise.com.

Business Structure

The Joint Corp. is a franchisor of clinics and an operator of clinics in certain states. In Arkansas, California, Colorado, District of Columbia, Florida, Illinois, Kansas, Kentucky, Maryland, Michigan, Minnesota, New Jersey, New York, North Carolina, Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee, Washington, West Virginia and Wyoming, The Joint Corp. and its franchisees provide management services to affiliated professional chiropractic practices.

Media Contact: Margie Wojciechowski, The Joint Corp., [email protected]
Investor Contact: Kirsten Chapman, LHA Investor Relations, 415-433-3777, [email protected]

 



Posted on

HempFusion’s Products Enter Asia Through Alibaba Group’s Tmall Global

HempFusion’s Products Enter Asia Through Alibaba Group’s Tmall Global

DENVER–(BUSINESS WIRE)–
HempFusion Wellness Inc. (TSX:CBD.U) (US:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness Company offering premium probiotic supplements and products containing CBD, is pleased to announce following its launch of Probulin Probiotics on Alibaba Group Holding’s Tmall Global (“Tmall”), it has now received conditional approval to launch HempFusion’s CBD products on Tmall, the world’s largest cross border online marketplace reaching more than 750 million potential new consumers across mainland China, Hong Kong, Macau and Taiwan.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210406005360/en/

(Graphic: Business Wire)

(Graphic: Business Wire)

“We are incredibly excited to receive approval for HempFusion’s flagship store from Tmall, joining our subsidiary, Probulin Probiotics, on China’s leading eCommerce platform reaching the world’s largest consumer base,” said Jon Visser, HempFusion’s Chief Revenue Officer. “To be one of the first publicly traded CBD companies on the platform provides us with significant competitive advantages that have the potential to add considerable revenue to our Company,’’ continued Mr. Visser.

HempFusion’s topicals with CBD are expected to launch on Tmall soon and will include its OTC drug listed Acne Relief, Eczema Relief, and Sports Relief Creams, Pain Relief and Sports Pain Relief Balms, Pain Relief Gel and Wound Ointment, with more products expected to follow. These unique formulations include a proprietary skin nourishing and moisturizing base with Aloe Vera, Shea butter, Jojoba oil, Hemp derived omega fatty acids and CBD, as well as many other botanicals.

“Building on our established relationship with the Alibaba Group and Tmall, and introducing our premium HempFusion OTC Drug Listed Topical products throughout this premier Asian eCommerce platform, has been a major focus of our strategic expansion plan,” stated Jason Mitchell, N.D., HempFusion’s Co-Founder and CEO. “We are now accessing one of the largest online consumer groups in the world with products formulated with approved drug monograph ingredients such as menthol for ailments such as pain. These products have already performed as best in class in select retailers in the United States, and we’re excited to see that follow through in the world’s largest market,” continued Dr. Mitchell.

Tmall, the third most visited website in the world, provides unique opportunities to raise brand awareness and drive conversions through comprehensive digital marketing campaigns, including shoppable live streams with product demonstrations and special offers. Brand hosts drive traffic through live, digital interaction, resulting in more engaged consumers staying tuned in longer.

“Our highest profile influencers are looking forward to engaging with the enormous Asian market through this live stream eCommerce format,” stated Mr. Visser. “They’ll deliver authentic, first-person testimonials and experiences, interacting and educating new consumers on the many wellness benefits of HempFusion products,” continued Mr. Visser.

HempFusion is ranked #2 in brand awareness according to a recent survey conducted by Brightfield Group. “Our goal is to achieve the same brand awareness and reach that top spot in Greater China,” added Dr. Mitchell.

ABOUT HEMPFUSION

HempFusion is a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition. HempFusion distributes its family of brands, including HempFusion, Probulin Probiotics, Biome Research, and HF Labs, to approximately 4,000 retail locations across all 50 states of the United States and select international locations. Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 48 SKUs including tinctures, proprietary FDA Drug Listed Over-The-Counter (OTC) Topicals, Doctor/Practitioner Lines and more. With a strong focus on research and development, HempFusion has an additional 30 products under development. HempFusion is a board member of the US Hemp Roundtable, and HempFusion’s wholly-owned subsidiary, Probulin Probiotics, is one of the fastest-growing probiotics companies in the United States, according to SPINs reported data. HempFusion’s CBD products are based on a proprietary Whole Food Hemp Complex™ and are available in-store or by visiting HempFusion online at www.hempfusion.com or www.probulin.com.

Follow HempFusion on Twitter, Facebook and Instagram and Probulin on Twitter, Facebook and Instagram.

FORWARD-LOOKING STATEMENTS

This news release contains forward-looking statements and forward-looking information within the meaning of Canadian securities legislation (collectively, “forward-looking statements“) that relate to HempFusion’s current expectations and views of future events. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, through the use of words or phrases such as “will likely result”, “are expected to”, “expects”, “will continue”, “is anticipated”, “anticipates”, “believes”, “estimated”, “intends”, “plans”, “forecast”, “projection”, “strategy”, “objective” and “outlook”) are not historical facts and may be forward-looking statements and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ materially from those expressed in such forward-looking statements. No assurance can be given that these expectations will prove to be correct and such forward-looking statements included in this news release should not be unduly relied upon. These statements speak only as of the date of this news release. In particular and without limitation, this news release contains forward-looking statements relating to the launch of the Company’s CBD products on Tmall and the timing and revenue opportunity thereof, planned launch of the Company’s additional brands in Greater China, the Company’s marketing and strategic expansion plans and the Company’s other plans, focus and objectives.

Forward-looking statements are based on a number of assumptions and are subject to a number of risks and uncertainties, many of which are beyond HempFusion’s control, which could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to, the impact and progression of the COVID-19 pandemic and other factors set forth under “Cautionary Note Regarding Forward Looking Statements” and “Risk Factors” in the annual information form of the Company dated March 31, 2021 and available under the Company’s profile on SEDAR at www.sedar.com. HempFusion undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. New factors emerge from time to time, and it is not possible for HempFusion to predict all of them or assess the impact of each such factor or the extent to which any factor, or combination of factors, may cause results to differ materially from those contained in any forward-looking statement. Any forward-looking statements contained in this news release are expressly qualified in their entirety by this cautionary statement.

Neither the TSX nor its Regulation Services Provider (as that term is defined in the policies of the TSX) accepts responsibility for the adequacy or accuracy of this release.

Jason Mitchell, N.D.

Chief Executive Officer and Director

Email: [email protected]

Phone: 416-803-5638

KEYWORDS: Colorado China Taiwan Macau Hong Kong North America Asia Pacific Canada United States

INDUSTRY KEYWORDS: General Health Online Retail Internet Pharmaceutical Specialty Technology Fitness & Nutrition Cosmetics Retail Marketing Communications Alternative Medicine Health

MEDIA:

Photo
Photo
(Graphic: Business Wire)
Logo
Logo
Posted on

Veritone to Hold First Quarter 2021 Results Conference Call on May 4th

Veritone to Hold First Quarter 2021 Results Conference Call on May 4th

COSTA MESA, Calif.–(BUSINESS WIRE)–Veritone, Inc. (NASDAQ: VERI), the creator of the world’s first operating system for artificial intelligence, aiWARE™, today announced the details of its first quarter 2021 results conference call.

Veritone will hold a conference call on Tuesday, May 4, 2021 at 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time) to discuss its results for the first quarter 2021, provide an update on the business, and conduct a question and answer session. To listen, please join the webcast or dial-in. To avoid a wait, if dialing in, please pre-register or call in 20 minutes in advance.

•

Preregister*:

https://dpregister.com/sreg/10154254/e62c6b4936

•

Live audio webcast:

investors.veritone.com

•

Domestic call number:

844-750-4897

•

International call number:

412-317-5293

•

Call ID:

10154254

* Callers who pre-register will be emailed, upon registering and again on the day of the call, a conference pass code and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time.

About Veritone

Veritone (NASDAQ: VERI) is a leading provider of artificial intelligence (AI) technology and solutions. The Company’s proprietary operating system, aiWARE™, powers a diverse set of AI applications and intelligent process automation solutions that are transforming both commercial and government organizations. aiWARE orchestrates an expanding ecosystem of machine learning models to transform audio, video, and other data sources into actionable intelligence. The Company’s AI developer tools enable its customers and partners to easily develop and deploy custom applications that leverage the power of AI to dramatically improve operational efficiency and unlock untapped opportunities. Veritone is headquartered in Denver, Colorado, and has offices in Costa Mesa, London, New York, and San Diego. To learn more, visit Veritone.com.

Company Contact:

Brian Alger, CFA

SVP, Corporate Development & Investor Relations

Veritone, Inc.

(949) 386-4318

[email protected]

Investor Relations Contact:

Kirsten Chapman

LHA Investor Relations

(415) 433-3777

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Software Technology Nanotechnology Electronic Design Automation

MEDIA:

Logo
Logo
Posted on

MediPharm Labs Achieves Export Milestone, Ships Cannabis Oil from Australia to Germany

  • MediPharm Labs exports commercial shipment of medical cannabis products approved by the Australian Therapeutic Goods Administration (TGA) to patients in Germany
  • An export milestone for the Australian cannabis industry as an export hub
  • Germany is one of the most heavily regulated export markets in the world, this export milestone strengthens MediPharm Labs’ and Australia’s position as a leader in medical cannabis production

BARRIE, Ontario, April 06, 2021 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced it has exported its first shipment of cannabis oil products, approved by the Australian TGA, to Germany. As a result, patients in Germany are now able to access GMP-certified quality medical cannabis through MediPharm Labs German distribution partners.

Only companies that have received Good Manufacturing Practices (GMP) certification are permitted to export cannabis products into the German market. Only a handful of companies have been successful in their attempts to export cannabis oils into the country. This achievement by MediPharm Labs demonstrates Australia’s pharmaceutical excellence and positions Australia as a global leader in the production of cannabis medicines.

“As this first shipment and first sales to Germany mark MediPharm Labs’ entry into the international pharmaceutical industry within a major European market, we are excited by the opportunities that lie ahead as we employ all of our value-added capabilities,” said Warren Everitt, CEO, MediPharm Labs Australia.

MediPharm Labs expects white label product shipments to its German customers to continue throughout 2021 and beyond. Upon full launch, MediPharm will work on innovating their offering for the German market and expand supply to other European countries where regulations allow.

Keith Strachan, President and Interim Chief Executive Officer commented, “I am proud of MediPharm Australia’s progress in licensing and operationalizing this unique GMP platform. This site Australian hub allows us to strengthen our focus of diversified revenue with multiple products in multiple jurisdictions.”

The Growing German Market

Cannabis has been permitted for therapeutic use in Germany since 2017 and may be prescribed by a doctor in the event of serious illnesses. With over 83 million inhabitants benefitting from broad access to healthcare services, Germany currently represents an estimated 75% of the current EU medical cannabis market. In 2020, more than 320,000 cannabis prescriptions approved in Germany, based on average from January – September extrapolated to 12 months.

The Medical Cannabis Network reports the medical cannabis market in Germany is currently valued at between €150m and €175m, despite only around 10% of the 20,000 pharmacies in Germany selling medical cannabis products today. With greater awareness and education, the Medical Cannabis Network estimates that Germany’s dominance in the European cannabis market could expand to €1.5bn by 2025.(1)

(1) https://www.healtheuropa.eu/exploring-growth-in-the-european-medical-cannabis-market/100849/

About MediPharm Labs

Founded in 2015, MediPharm Labs specializes in the production of purified, pharmaceutical-quality cannabis oil and concentrates and advanced derivative products utilizing a Good Manufacturing Practices certified facility with ISO standard-built clean rooms. MediPharm Labs has invested in an expert, research driven team, state-of-the-art technology, downstream purification methodologies and purpose-built facilities with five primary extraction lines for delivery of pure, trusted and precision-dosed cannabis products for its customers. Through its wholesale and white label platforms, MediPharm Labs formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. As a global leader, MediPharm Labs has completed commercial exports to Australia and has fully commercialized its Australian extraction facility. MediPharm Labs Australia was established in 2017.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION

This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking statements”) within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward-looking statements relate to, among other things, the successful shipping of products as planned; expectations that white label product shipments to German distributors will continue in throughout 2021 and beyond; the Company innovating its offering for the German market; the expansion of supply to other European countries where regulations allow; forecasts regarding the growth of the German cannabis market; and opportunities that lie ahead as the Company employs its value-added capabilities. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; the inability of MediPharm Labs to obtain adequate financing; the delay or failure to receive regulatory approvals; and other factors discussed in MediPharm Labs’ filings, available on the SEDAR website at www.sedar.com. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release. Except as required by law, MediPharm Labs assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change.



For further information, please contact:
Laura Lepore, VP, Investor Relations and Communications
Telephone: 416-913-7425 ext. 1525
Email: [email protected]
Website: www.medipharmlabs.com

Posted on

Boardwalk REIT Provides an Operational Update and Timing of Release of its 2021 First Quarter Financial Results

PR Newswire

CALGARY, AB, April 6, 2021 /PRNewswire/ – Boardwalk Real Estate Investment Trust – TSX: BEI.UN

Boardwalk REIT (“Boardwalk”, “the Trust”, “We”), as part of the Trust’s commitment to providing regular updates through the COVID pandemic, the following is a brief update highlighting stabilized portfolio occupancy, rental revenue collection rates and occupied rents available to date as we continue to focus on our essential service of providing safe homes to Boardwalk’s Resident Members through this COVID-19 pandemic. 


Stabilized Portfolio Occupancy, Rental Revenue Collection, and Occupied Rent

Nov-20

Dec-20

Jan-21

Feb-21

Mar-21

Apr-21


Stabilized Portfolio
Occupancy

95.8%

95.2%

94.8%

94.7%

95.0%

95.7%


1
 Occupancy as of the first day of each month

 

Nov-20

Dec-20

Jan-21

Feb-21

Mar-21


Rental Revenue
Collection

98.0%

98.5%

98.4%

98.4%

98.8%


2
 % of rental revenue collected for the month as the last day of each respective period

 

Nov-20

Dec-20

Jan-21

Feb-21


Occupied Rent

$1,187

$1,189

$1,190

$1,189


3
 Ancillary rental revenue is included in the calculation of occupied rent, March figure TBA with Q1 Results

 

Sam Kolias, Chairman and Chief Executive Officer of Boardwalk REIT commented:

“We are pleased to provide an update on the positive trends previously shared with our disclosures in February.  Boardwalk’s move-ins exceeded move-outs in the months of January, February and March which have led to a significant 100 basis point gain in occupancy to 95.7%. 

We cannot thank our Boardwalk team of heroes enough for continuing to provide safe and affordable homes for our Resident Members, as our brand of product quality, service and experience continues to lead in market share and performance. 

With vaccinations well underway, our largest market of Alberta continues to see positive leading indicators for housing demand.  Population growth of 0.8% in the first quarter (1.0% in Q4, 2020) continues to lead all provinces on a proportionate basis.  This population growth combined with low interest rates, improving sentiment in the energy sector, and steady news of companies choosing Alberta as the place they call home, is leading to record home sales and a balancing of the housing market through this pandemic.  The Alberta government has recently announced a return to in-person learning at our post-secondary institutions this September which has led to a return of students, further increasing housing demand.  Economic and rental market indicators continue to reflect Alberta’s economic rebound which is grounded on some of the most affordable and desirable housing in Canada as we transition to the endemic economy. 

I would like to thank our entire peak performance Team of Associates who continue to provide our essential service of safe and affordable housing.  We look forward to sharing full details of our first quarter financial results in May.”


Retirement of Lisa Russell, Senior Vice President; Corporate Development

Lisa Russell, the Trust’s Senior Vice President of Corporate Development has provided the Trust with her intention to retire effective June 30, 2021.  Sam Kolias; Chairman and CEO commented:

“On behalf of our entire Boardwalk team and family, we are forever grateful for the contributions and leadership that Lisa has provided over her 25+ year career with Boardwalk.  Lisa has been a tremendous leader in Boardwalk’s acquisition, disposition and growth strategy during her time with the Trust and has mentored a strong team capable of taking Boardwalk’s growth into the future.  The Boardwalk family wishes Lisa an even more amazing future.”


2020 ESG and Annual Report

Boardwalk is proud to publish its 2020 ESG and Annual reports.  Both reports are available as interactive digital reports on the Trust’s website: www.bwalk.com/investors


Timing of Boardwalk REIT’s First Quarter Financial Results

Boardwalk REIT’s financial results for the three-month period ended March 31, 2021, will be released the evening of May 13, 2021.

We invite you to participate in the teleconference to be held to discuss these results the following morning (Friday May 14, 2021) at 9:00 am (Mountain),11:00 am (Eastern).  Senior Management will speak to the results and provide a financial and operational update.  Presentation and supplemental materials will be made available on our website prior to the call (please visit: www.bwalk.com/investors).

Teleconference: 

The telephone numbers for the conference are toll-free 1-888-664-6383 (within North America) and 416-764-8650 (International).

Note: Please provide the operator with the below Conference Call ID or Topic when dialing in to the call.

Conference ID: 83723046
Topic: Boardwalk Real Estate Investment Trust, 2021 First Quarter Results.

Webcast: 

Investors will also be able to listen to the call and view the slide presentation by visiting www.bwalk.com/investors on the morning of the call.  An information page will be provided for any software and system requirements.  The live webcast will also be available by clicking below:

Boardwalk REIT First Quarter Results Webcast Link


Corporate Profile:

Boardwalk REIT strives to provide Canada’s friendliest communities, where love always lives™, and currently owns and operates more than 200 communities with over 33,000 residential units totaling over 28 million net rentable square feet.  Boardwalk’s principal objectives are to provide its Residents with the best quality communities and superior customer service, while providing Unitholders with enhanced returns by increasing the value of its Trust Units through selective acquisitions, dispositions, development, and effective management of its residential multi-family communities.  Boardwalk REIT is vertically integrated and is Canada’s leading owner/operator of multi-family communities bringing Residents home to properties located in Alberta, Saskatchewan, Ontario, and Quebec.

Boardwalk REIT’s Trust Units are listed on the Toronto Stock Exchange, trading under the symbol BEI.UN.  Additional information about Boardwalk REIT can be found on the Trust’s website at www.bwalk.com/investors.

Cision View original content:http://www.prnewswire.com/news-releases/boardwalk-reit-provides-an-operational-update-and-timing-of-release-of-its-2021-first-quarter-financial-results-301262534.html

SOURCE Boardwalk Real Estate Investment Trust

Posted on

Signet Jewelers Boosts Services Offerings with Acquisition of Rocksbox, the Leading Jewelry Rental Subscription Platform

Combined companies to scale data-driven, consumer-inspired membership model

PR Newswire

AKRON, Ohio, April 6, 2021 /PRNewswire/ — Signet Jewelers Limited (NYSE: SIG), the world’s largest retailer of diamond jewelry, today announced it has acquired Rocksbox, an innovative jewelry rental subscription platform, giving it a significant foothold in a growing online service that speaks to next-generation jewelry customers. The acquisition is driven by Signet’s “Inspiring Brilliance” strategy and is intended to accelerate growth in the services category. 

“I’m delighted to welcome the talented Rocksbox team to our Signet family and am confident this union will generate exciting opportunities to accelerate our growth in services and reach new customers,” said Signet CEO Virginia C. Drosos. “Under CEO Meaghan Rose’s leadership, Rocksbox has revolutionized the jewelry rental subscription marketplace by delivering personalized, online and data-driven customer experiences for jewelry lovers who prioritize fashion, online convenience and sustainability. We look forward to bringing Rocksbox’s outstanding services to more customers, and to introducing those new customers to the balance of Signet’s banners.”

Rocksbox was launched in 2012 by Rose, a jewelry lover and former strategy consultant, with an inspiring mission: “To bring the joy of jewelry to every person.”  Rocksbox invites monthly members to rent and swap exclusive and designer jewelry styles, using its intuitive online platform. Today, the company’s growing customer base consists of women who are stylish and tech savvy. Rocksbox is a leader in the circular economy, ensuring customers have the latest trending jewelry at an affordable price point while also delivering sustainability benefits as items are circulated and re-used throughout the marketplace. Rocksbox further strengthens Signet’s industry-leading portfolio of banners that includes Kay, Zales, Jared, Peoples, jamesallen.com, H. Samuel, Ernest Jones, and Piercing Pagoda. It provides an additional point of entry for self-purchasing women customers, a segment where Signet is currently under-developed, and is expected to help Signet continue extending its market share.

“We are excited to join Signet and to play an important role in its purpose-driven growth strategy – Inspiring Brilliance – while also taking the company we’ve so passionately grown to an entirely new level,” said Meaghan Rose, founder and CEO of Rocksbox. “I started Rocksbox to make it easy and fun for women to discover jewelry that they love – and that won’t change. We’re excited to give even more members the opportunity to experiment with new, fashionable jewelry styles through a technology-enabled, personalized rental experience. As a customer-first, data-driven and values-oriented company, we were selective about finding the right partner. I am proud to join the Signet team and excited about the opportunities this alignment brings.”

Signet recently announced that it is focusing on the acceleration of its Services business as part of the company’s Inspiring Brilliance growth strategy. The company expects to expand its current services such as repair, warranty services and piercings, while also introducing new ones. With jewelry rental subscription, Signet will tap into a highly engaged customer base, generate a new revenue stream, and bring yet another capability into its connected-commerce strategy, which is focused on serving customers whenever, wherever and however they want to engage with Signet and its retail banners.

About Signet and Safe Harbor Statement:

Signet Jewelers Limited is the world’s largest retailer of diamond jewelry.  As a purpose-driven and sustainability focused company, Signet is a participant in the United Nations Global Compact, and adheres to its principles-based approach to responsible business. Signet is a Best Places to Work certified™ company and has been named to the Bloomberg® Gender Equality Index for three consecutive years. Signet operates approximately 2,800 stores primarily under the name brands of Kay Jewelers, Zales, Jared, H. Samuel, Ernest Jones, Peoples, Piercing Pagoda, and JamesAllen.com. Further information on Signet is available at www.signetjewelers.com. See  also www.kay.com, www.zales.com, www.jared.com, www.hsamuel.co.uk, www.ernestjones.co.uk, 
www.peoplesjewellers.com, www.pagoda.com, and www.jamesallen.com.

This release contains statements which are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements, based upon management’s beliefs and expectations as well as on assumptions made by and data currently available to management, appear in a number of places throughout this document and include statements regarding, among other things, Signet’s results of operation, financial condition, liquidity, prospects, growth, strategies and the industry in which Signet operates. The use of the words “expects,” “intends,” “anticipates,” “estimates,” “predicts,” “believes,” “should,” “potential,” “may,” “preliminary,” “forecast,” “objective,” “plan,” or “target,” and other similar expressions are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to a number of risks and uncertainties which could cause the actual results to not be realized, including, but not limited to: the negative impacts that the COVID-19 pandemic has had, and will continue to have, on Signet’s business, financial condition, profitability and cash flows; the effect of steps we take in response to the pandemic; the severity and duration of the pandemic, including whether it is necessary to temporarily reclose our stores, distribution centers and corporate facilities or for our suppliers and vendors to temporarily reclose their facilities; the pace of recovery when the pandemic subsides and the heightened impact it has on many of the risks described herein, including without limitation risks relating to disruptions in our supply chain, consumer behaviors such as spending and willingness to congregate in shopping centers and the impact on demand of our products, our level of indebtedness and covenant compliance, availability of adequate capital, our ability to execute our business plans, our lease obligations and relationships with our landlords, and asset impairments; general economic or market conditions; financial market risks; our ability to optimize Signet’s transformation initiative; a decline in consumer spending or deterioration in consumer financial position; changes to regulations relating to customer credit; disruption in the availability of credit for customers and customer inability to meet credit payment obligations; our ability to achieve the benefits related to the outsourcing of the credit portfolio, including due to technology disruptions, future financial results and operating results and/or disruptions arising from changes to or termination of the relevant non-prime outsourcing agreement requiring transition to alternative arrangements through other providers or alternative payment options and our ability to successfully establish future arrangements for the forward-flow receivables; deterioration in the performance of individual businesses or of the Company’s market value relative to its book value, resulting in impairments of long-lived assets or intangible assets or other adverse financial consequences; the volatility of our stock price; the impact of financial covenants, credit ratings or interest volatility on our ability to borrow; our ability to maintain adequate levels of liquidity for our cash needs, including debt obligations, payment of dividends, and capital expenditures as well as the ability of our customers, suppliers and lenders to access sources of liquidity to provide for their own cash needs; changes in our credit rating; potential regulatory changes, global economic conditions or other developments related to the United Kingdom’s exit from the European Union; exchange rate fluctuations; the cost, availability of and demand for diamonds, gold and other precious metals; stakeholder reactions to disclosure regarding the source and use of certain minerals; seasonality of Signet’s business; the merchandising, pricing and inventory policies followed by Signet and failure to manage inventory levels; Signet’s relationships with suppliers including the ability to continue to utilize extended payment terms and the ability to obtain merchandise that customers wish to purchase; the failure to adequately address the impact of existing tariffs and/or the imposition of additional duties, tariffs, taxes and other charges or other barriers to trade or impacts from trade relations; the level of competition and promotional activity in the jewelry sector; our ability to optimize Signet’s multi-year strategy to gain market share, expand and improve existing services, innovate and achieve sustainable, long-term growth; the maintenance and continued innovation of Signet’s Omni-Channel retailing and ability to increase digital sales; changes in consumer attitudes regarding jewelry and failure to anticipate and keep pace with changing fashion trends; changes in the supply and consumer acceptance of and demand for gem quality lab created diamonds and adequate identification of the use of substitute products in our jewelry; ability to execute successful marketing programs and manage social media; the ability to optimize Signet’s real estate footprint; the ability to satisfy the accounting requirements for “hedge accounting,” or the default or insolvency of a counterparty to a hedging contract; the performance of and ability to recruit, train, motivate and retain qualified sales associates; management of social, ethical and environmental risks; the reputation of Signet and its banners; inadequacy in and disruptions to internal controls and systems, including related to the migration to a new financial reporting information technology system; security breaches and other disruptions to Signet’s information technology infrastructure and databases; an adverse development in legal or regulatory proceedings or tax matters, including any new claims or litigation brought by employees, suppliers, consumers or shareholders, regulatory initiatives or investigations, and ongoing compliance with regulations and any consent orders or other legal or regulatory decisions; failure to comply with labor regulations; collective bargaining activity; changes in taxation laws, rules or practices in the US and jurisdictions in which Signet’s subsidiaries are incorporated, including developments related to the tax treatment of companies engaged in Internet commerce; risks related to international laws and Signet being a Bermuda corporation; difficulty or delay in executing or integrating an acquisition, business combination, major business or strategic initiative; risks relating to the outcome of pending litigation; our ability to protect our intellectual property or physical assets; changes in assumptions used in making accounting estimates relating to items such as extended service plans and pensions; the success of recent changes in Signet’s executive management team; or the impact of weather-related incidents, natural disasters, strikes, protests, riots or terrorism, acts of war or another public health crisis or disease outbreak, epidemic or pandemic on Signet’s business.

For a discussion of these and other risks and uncertainties which could cause actual results to differ materially from those expressed in any forward-looking statement, see Item 1A, Risk Factors, and elsewhere in the Annual Report on Form 10-K for the year ended January 30, 2021 filed with the SEC on March 19, 2021. Signet undertakes no obligation to update or revise any forward-looking statements to reflect subsequent events or circumstances, except as required by law.

Investors:

Vinnie Sinisi

SVP Investor Relations & Treasury
[email protected]

Media:

Colleen Rooney

Chief Communications & ESG Officer
[email protected]

David Bouffard

VP Corporate Affairs    
[email protected]

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/signet-jewelers-boosts-services-offerings-with-acquisition-of-rocksbox-the-leading-jewelry-rental-subscription-platform-301262720.html

SOURCE Signet Jewelers Ltd.

Posted on

Starwood Property Trust Announces Date for First Quarter 2021 Earnings Release and Conference Call

PR Newswire

GREENWICH, Conn., April 6, 2021 /PRNewswire/ — Starwood Property Trust (NYSE: STWD) today announced that the Company will release its first quarter 2021 financial results on Thursday, May 6, 2021 before the opening of trading on the New York Stock Exchange. A conference call will be held on Thursday, May 6, 2021 at 10:00 a.m. Eastern Time.

During the conference call, the Company’s officers will review first quarter performance, discuss recent events and conduct a question-and-answer period.

Webcast
The conference call will also be available in the Investor Relations section of the Company’s website at www.starwoodpropertytrust.com. To listen to a live broadcast, go to the site at least 15 minutes prior to the scheduled start time in order to register, download and install any necessary audio software. A replay of the call will also be available for 90 days on the Company’s website.

To Participate in the Telephone Conference Call:
Dial in at least five minutes prior to start time.
Domestic: 1-877-407-9039
International: 1-201-689-8470

Conference Call Playback:
Domestic: 1-844-512-2921
International: 1-412-317-6671
Passcode: 13718432
The playback can be accessed through May 13, 2021.

Full Text of the Earnings Release

  • Internet — The full text of the earnings release will be available on Thursday, May 6, 2021 at the Company’s web site, www.starwoodpropertytrust.com.
  • Mail — For those without Internet access, the first quarter earnings release will be available by mail or fax, on request. To receive a copy, please call the Company’s Investor Relations line at 203-422-7788.

About Starwood Property Trust, Inc.

Starwood Property Trust (NYSE: STWD), is a leading diversified finance company with a core focus on the real estate and infrastructure sectors. An affiliate of global private investment firm Starwood Capital Group, the Company has successfully deployed over $68 billion of capital since inception and manages a portfolio of over $18 billion across debt and equity investments. Starwood Property Trust’s investment objective is to generate attractive and stable returns for shareholders, primarily through dividends, by leveraging a premiere global organization to identify and execute on the best risk adjusted returning investments across its target assets. Additional information can be found at www.starwoodpropertytrust.com.

Contact:

Zachary Tanenbaum

Starwood Property Trust
Phone: 203-422-7788
Email: [email protected]

Cision View original content:http://www.prnewswire.com/news-releases/starwood-property-trust-announces-date-for-first-quarter-2021-earnings-release-and-conference-call-301262717.html

SOURCE Starwood Property Trust, Inc.

Posted on

Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter 2021 Financial Results

PR Newswire

MINNEAPOLIS, April 6, 2021 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Thursday, May 6, 2021, at 8:00 a.m. CDT to review third quarter 2021 financial results.

Access to the discussion may be obtained as follows:

Time:

8:00 a.m. CDT

Date:

May 6, 2021

Dial-in:

1-877-407-9208 or 1-201-493-6784 (for international callers)

Conference ID:

13718437

Webcast:


http://public.viavid.com/index.php?id=144241

A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by dialing 1-844-512-2921 or 1-412-317-6671 (for international callers) and referencing Conference ID 13718437.

The replay will be available from 11:00 a.m. CDT on Thursday, May 6, 2021 until 11:00 p.m. CDT on Sunday, June 6, 2021.

Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purified proteins and reagent solutions – notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents and T-Cell activation technologies. Bio-Techne’s product portfolio also includes protein analysis solutions, sold under the ProteinSimple brand name, offering researchers efficient and streamlined options for automated western blot and multiplexed ELISA workflow. These reagent and protein analysis solutions are sold to biomedical researchers as well as clinical research laboratories and constitute the Protein Sciences Segment. Bio-Techne also develops and manufactures diagnostic products including FDA-regulated controls, calibrators, blood gas and clinical chemistry controls and custom assay development on dedicated clinical instruments. Bio-Techne’s genomic tools include advanced tissue-based in-situ hybridization assays (ISH) for research and clinical use, sold under the ACD brand as well as a portfolio of clinical molecular diagnostic oncology assays, including the ExoDx®Prostate(IntelliScore) test (EPI) for prostate cancer diagnosis. These diagnostic and genomic products comprise Bio-Techne’s Diagnostics and Genomics Segment. Bio-Techne products are integral components of scientific investigations into biological processes and molecular diagnostics, revealing the nature, diagnosis, etiology and progression of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $739 million in net sales in fiscal 2020 and has approximately 2,300 employees worldwide.

Contact:

David Clair, Senior Director, Investor Relations & Corporate Development


[email protected]

612-656-4416  

 

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/bio-techne-to-host-conference-call-on-may-6-2021-to-announce-third-quarter-2021-financial-results-301262687.html

SOURCE Bio-Techne Corporation